Predicting hypertensive disorders in pregnancy using multiple methods: Models with the placental growth factor parameter

Technol Health Care. 2021;29(S1):427-432. doi: 10.3233/THC-218040.

Abstract

Background: Placental growth factor (PlGF), one of the biomarkers, has a certain predictive effect on hypertensive disorders in pregnancy (HDP).

Objective: To study the HDP prediction effect of different methods for variable selection and modeling for models containing PlGF.

Methods: For the model containing PlGF, the appropriate range of PlGF parameters needed to be selected. Step-logistic regression and lasso were used to compare the model effect of twice range selection. The PlGF model with good predictive effect and appropriate detecting gestational age was selected for the final prediction.

Results: The effect of the model containing PlGF tested at 15-16 weeks was better than the PlGF value without comprehensive screening. The sensitivity of both methods was over 92%. By comprehensive comparison, the final model of lasso method in this study was more effective.

Conclusions: In this study, a variety of methods were used to screen models containing PlGF parameters. According to clinical needs and model effects, the optimal HDP prediction model with PlGF parameters in the second trimester of 15-26 weeks of pregnancy was finally selected.

Keywords: Placental growth factor; model parameters; variable selection.

MeSH terms

  • Biomarkers
  • Female
  • Gestational Age
  • Humans
  • Hypertension, Pregnancy-Induced* / diagnosis
  • Placenta Growth Factor
  • Pregnancy

Substances

  • Biomarkers
  • Placenta Growth Factor